Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Thermo Scientific™ Spectra™ ESBL Medium

Catalog No. R01810
Change view
Click to view available options
Quantity:
10/Pk.
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
R01810 10/Pk.
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. R01810 Supplier Thermo Scientific™ Supplier No. R01810
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Rapidly isolate and presumptively identify Extended Spectrum Beta-Lactamase (ESBL)-producing Enterobacteriaceae while selectively inhibiting non-ESBL Enterobacteriaceae, and some AmpC organisms and other non-ESBL flora.

Rapidly isolate and presumptively identify Extended Spectrum Beta-Lactamase (ESBL)-producing Enterobacteriaceae whilst selectively inhibiting non-ESBL Enterobacteriaceae, and some AmpC organisms and other non-ESBL flora, with Thermo Scientific™ Spectra™ ESBL Medium. The FDA-cleared chromogenic medium facilitates earlier intervention through enabling positive screen results in 18 to 24 hours directly from perirectal swabs or fresh stool specimens. The medium reduces the amount of confirmatory work-up and the costs incurred due to unnecessary isolation and additional testing.

Extended Spectrum β Lactamases are enzymes capable of conferring bacterial resistance to penicillins, cephalosporins, and aztreonam by hydrolysis of these antibiotics 1,2. Production of ESBLs is a significant resistance-mechanism that impedes the antimicrobial treatment of infections caused by Enterobacteriaceae and is a serious threat to the currently available antibiotic armory 3.

Spectra ESBL Medium supports HAI surveillance programs through fast isolation and presumptive identification of ESBL-producing bacteria in clinical samples.
  • Easy-to-read: clearly differentiates ESBL-producing organisms by their blue/turquoise-green or pink colonies.
  • Facilitates early intervention: fast, accurate results support infection prevention and control.
  • High specificity: reduces costs associated with unnecessary isolation and additional testing.
  • Streamlined workflow: screen positive within 18 to 24 hours directly from perirectal swabs or fresh stool specimens.
  • Ready-to-use: convenience of prepared media.
  • First FDA-cleared chromogenic media for the presumptive identification of Proteus.
A mixture of chromogens forms a substrate for two enzymes: β-galactosidase and glucuronidase that are differentially expressed in different species of bacteria resulting in blue/turquoise-green or pink colonies. Other ESBL-producing organisms that do not utilize the chromogenic substrates may produce tan colonies through deamination of tryptophan. Non-target organisms generally appear cream colored or are naturally pigmented green or brown.

The main ESBL-producing bacteria include: Escherichia coliKlebsiella pneumoniaeKlebsiella oxytoca and Proteus mirabilis. Accurate and rapid detection of ESBL-producing bacteria is essential to assist in the selection of appropriate antibiotic therapy, avoid treatment failures in patients, and prevent further transmission of these multi-drug-resistant organisms.4,5

Not all products are available for sale in all territories. Please inquire.
TRUSTED_SUSTAINABILITY

Specifications

Color White opaque
Content And Storage 2°C to 8°C
Description Spectra ESBL Medium
Format 85mm plate
Packaging Type Cellophane
Quantity 10/Pk.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.